{"transactions":[{"id":1933817,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T16:35:29.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":7885,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted pursuant to the 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan.  Each RSU represents a contingent right to receive one share of common stock upon the vesting date.  The RSUs vest as follows:  3,943 shares vest on April 15, 2023 and 3,942 shares vest on December 31, 2023. The vesting of the December 31, 2023 RSUs will accelerate upon a Change in Control prior to December 31, 2023."}],"balance_after":85907,"source":{"system":"sec-edgar","filing":"0001578563-23-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000157856323000014/primary_doc.xml","form_type":"4"}},{"id":2203167,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-07-22T16:21:02.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":175000,"price":0.2455,"value":42962.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.21 to $0.27, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1560427.55,"source":{"system":"sec-edgar","filing":"0001551986-22-000074","document":"wf-form4a_165852124664941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198622000074/wf-form4a_165852124664941.xml","form_type":"4/A","original_submission_date":"2022-07-06"}},{"id":2211530,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-07-06T16:43:12.000Z","date":"2022-07-01","kind":"purchase","acquired":true,"shares":175000,"price":0.2455,"value":42962.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.21 to $0.27, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1454044.55,"source":{"system":"sec-edgar","filing":"0001551986-22-000067","document":"wf-form4_165714016326083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198622000067/wf-form4_165714016326083.xml","form_type":"4"}},{"id":2222842,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T16:07:34.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":142509,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning June 22, 2022, subject to the director's continued service with the Company at each vest date."}],"balance_after":142509,"derivative":{"exercise_price":0.2649,"expiration_date":"2032-06-22","underlying":"Common stock","underlying_shares":142509},"source":{"system":"sec-edgar","filing":"0001551986-22-000062","document":"wf-form4_165601483991922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198622000062/wf-form4_165601483991922.xml","form_type":"4"}},{"id":2263324,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T16:01:16.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":106383,"price":0.47,"value":50000.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.46 to $0.47 inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1385427.55,"source":{"system":"sec-edgar","filing":"0001578563-22-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000157856322000016/primary_doc.xml","form_type":"4"}},{"id":2321946,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:15:50.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":85760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":3.66,"underlying":"Common Stock","underlying_shares":85760},"source":{"system":"sec-edgar","filing":"0001103021-22-000071","document":"wf-form4_164798373131962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000071/wf-form4_164798373131962.xml","form_type":"4"}},{"id":2321945,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:15:50.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":3.76,"underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001103021-22-000071","document":"wf-form4_164798373131962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000071/wf-form4_164798373131962.xml","form_type":"4"}},{"id":2321944,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:15:50.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":4.36,"underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001103021-22-000071","document":"wf-form4_164798373131962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000071/wf-form4_164798373131962.xml","form_type":"4"}},{"id":2321943,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-03-22T17:15:50.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Immediately prior to the Effective Time, each Issuer option that was outstanding and then exercisable for a per share exercise price less than the Merger Consideration that would be payable in respect of the Shares underlying such Issuer option (any such Issuer option, an \"In-the-Money Cash Out Option\") was cancelled and automatically converted into the right to receive for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the excess of the Merger Consideration over the per share exercise price of such In-the-Money Cash Out Option. All Issuer options that were not In-the-Money Cash Out Options were cancelled at the Effective Time without payment of any consideration."}],"balance_after":0,"derivative":{"exercise_price":4.96,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001103021-22-000071","document":"wf-form4_164798373131962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000071/wf-form4_164798373131962.xml","form_type":"4"}},{"id":2321942,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-03-22T17:15:50.000Z","date":"2022-03-22","kind":"disposition_to_issuer","acquired":false,"shares":11685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Issuer RSUs that was outstanding immediately prior to the Effective Time, was cancelled and converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding taxes, an amount in cash equal to the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11685},"source":{"system":"sec-edgar","filing":"0001103021-22-000071","document":"wf-form4_164798373131962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000071/wf-form4_164798373131962.xml","form_type":"4"}},{"id":2321941,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T17:15:50.000Z","date":"2022-03-22","kind":"other","acquired":false,"shares":1166866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 14, 2022, by and among the Issuer, Collegium Pharmaceutical, Inc., (\"Parent\"), and Bristol Acquisition Company Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of Issuer, $0.001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 22, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $5.60 in cash (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001103021-22-000071","document":"wf-form4_164798373131962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000071/wf-form4_164798373131962.xml","form_type":"4"}},{"id":2347370,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-03-07T08:01:55.000Z","date":"2022-03-03","kind":"purchase","acquired":true,"shares":86449.55,"price":0.5784,"value":50002.41972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.5755 to $0.5799, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":1279044.55,"source":{"system":"sec-edgar","filing":"0001551986-22-000023","document":"wf-form4_164665810128470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198622000023/wf-form4_164665810128470.xml","form_type":"4"}},{"id":2421355,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-31T18:04:28.000Z","date":"2022-01-27","kind":"exercise","acquired":false,"shares":7684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":7685,"derivative":{"exercise_price":0,"expiration_date":"2023-01-27","underlying":"Common Stock","underlying_shares":7684},"source":{"system":"sec-edgar","filing":"0001103021-22-000023","document":"wf-form4_164367024064927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000023/wf-form4_164367024064927.xml","form_type":"4"}},{"id":2421354,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-31T18:04:28.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":15369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":15369,"derivative":{"exercise_price":0,"expiration_date":"2023-01-27","underlying":"Common Stock","underlying_shares":15369},"source":{"system":"sec-edgar","filing":"0001103021-22-000023","document":"wf-form4_164367024064927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000023/wf-form4_164367024064927.xml","form_type":"4"}},{"id":2421353,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-01-31T18:04:28.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":85760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Plan. The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":85760,"derivative":{"exercise_price":3.66,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":85760},"source":{"system":"sec-edgar","filing":"0001103021-22-000023","document":"wf-form4_164367024064927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000023/wf-form4_164367024064927.xml","form_type":"4"}},{"id":2421352,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-31T18:04:28.000Z","date":"2022-01-27","kind":"exercise","acquired":true,"shares":7684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person on January 27, 2022, as compensation for service on the Issuer's board of directors, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (\"the Plan\"). The award is subject to time-based vesting and vests in equal portions on: (i) January 27, 2022; and (ii) January 27, 2023."}],"balance_after":1166866,"source":{"system":"sec-edgar","filing":"0001103021-22-000023","document":"wf-form4_164367024064927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302122000023/wf-form4_164367024064927.xml","form_type":"4"}},{"id":2478326,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2021-12-10T23:02:10.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":170000,"derivative":{"exercise_price":4.46,"exercise_date":"2022-12-09","expiration_date":"2031-12-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001513162-21-000148","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316221000148/primary_doc.xml","form_type":"4"}},{"id":2484114,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-06T08:06:27.000Z","date":"2021-12-02","kind":"purchase","acquired":true,"shares":18587,"price":2.69,"value":49999.03,"ownership":{"direct":true},"balance_after":1159182,"source":{"system":"sec-edgar","filing":"0001103021-21-000124","document":"wf-form4_163879597314892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000124/wf-form4_163879597314892.xml","form_type":"4"}},{"id":2485234,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-03T07:34:12.000Z","date":"2021-12-02","kind":"purchase","acquired":true,"shares":50000,"price":0.89,"value":44500.0,"ownership":{"direct":true},"balance_after":1242595,"source":{"system":"sec-edgar","filing":"0001578563-21-000044","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000157856321000044/primary_doc.xml","form_type":"4"}},{"id":2500383,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-11-22T07:30:08.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":20000,"price":1.06,"value":21200.0,"ownership":{"direct":true},"balance_after":1192595,"source":{"system":"sec-edgar","filing":"0001551986-21-000122","document":"wf-form4_163758419484127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198621000122/wf-form4_163758419484127.xml","form_type":"4"}},{"id":2503352,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T17:20:35.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":10000,"price":3.04,"value":30400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4/A is being filed to amend the Form 4 filed on November 19, 2021 (the \"Original Form 4\"). The Original Form 4 incorrectly used transaction code \"S,\" instead of transaction code \"P.\""}],"balance_after":1140595,"source":{"system":"sec-edgar","filing":"0001103021-21-000118","document":"wf-form4a_163736041498722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000118/wf-form4a_163736041498722.xml","form_type":"4/A","original_submission_date":"2021-11-19"}},{"id":2503351,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T08:15:48.000Z","date":"2021-11-18","kind":"sale","acquired":true,"shares":10000,"price":3.04,"value":30400.0,"ownership":{"direct":true},"balance_after":1140595,"source":{"system":"sec-edgar","filing":"0001103021-21-000116","document":"wf-form4_163732773186536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000116/wf-form4_163732773186536.xml","form_type":"4"}},{"id":2515809,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-12T08:03:19.000Z","date":"2021-11-11","kind":"purchase","acquired":true,"shares":16000,"price":3.2,"value":51200.0,"ownership":{"direct":true},"balance_after":1130595,"source":{"system":"sec-edgar","filing":"0001103021-21-000112","document":"wf-form4_163672218476101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000112/wf-form4_163672218476101.xml","form_type":"4"}},{"id":2575764,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-09-08T08:15:52.000Z","date":"2021-09-07","kind":"purchase","acquired":true,"shares":73529,"price":1.36,"value":99999.44,"ownership":{"direct":true},"balance_after":1172595,"source":{"system":"sec-edgar","filing":"0001551986-21-000101","document":"wf-form4_163110333513494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198621000101/wf-form4_163110333513494.xml","form_type":"4"}},{"id":2591186,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-25T16:37:18.000Z","date":"2021-08-23","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on August 23, 2021 (the \"Effective Date\"), as compensation for service on the Company's board of directors. The RSUs vest as follows: (i) 4,000 RSUs vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 4,000 RSUs will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":4000,"derivative":{"exercise_price":0,"expiration_date":"2022-08-23","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001103021-21-000082","document":"wf-form4_162992381258598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000082/wf-form4_162992381258598.xml","form_type":"4"}},{"id":2591185,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-25T16:37:18.000Z","date":"2021-08-23","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on August 23, 2021 (the \"Effective Date\"), as compensation for service on the Company's board of directors. The RSUs vest as follows: (i) 4,000 RSUs vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 4,000 RSUs will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":8000,"derivative":{"exercise_price":0,"expiration_date":"2022-08-23","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001103021-21-000082","document":"wf-form4_162992381258598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000082/wf-form4_162992381258598.xml","form_type":"4"}},{"id":2591184,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-08-25T16:37:18.000Z","date":"2021-08-23","kind":"grant","acquired":true,"shares":48000,"price":3.76,"value":180480.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options (\"options\") were issued to the Reporting Person on the Effective Date, as compensation for service on the Company's board of directors. The options vest as follows: (i) 24,000 options vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 24,000 options will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":48000,"derivative":{"exercise_price":3.76,"expiration_date":"2031-08-23","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001103021-21-000082","document":"wf-form4_162992381258598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000082/wf-form4_162992381258598.xml","form_type":"4"}},{"id":2591183,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T16:37:18.000Z","date":"2021-08-23","kind":"exercise","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on August 23, 2021 (the \"Effective Date\"), as compensation for service on the Company's board of directors. The RSUs vest as follows: (i) 4,000 RSUs vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 4,000 RSUs will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":1114595,"source":{"system":"sec-edgar","filing":"0001103021-21-000082","document":"wf-form4_162992381258598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000082/wf-form4_162992381258598.xml","form_type":"4"}},{"id":2593390,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-08-23T08:15:12.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":25000,"price":1.1,"value":27500.0,"ownership":{"direct":true},"balance_after":1099066,"source":{"system":"sec-edgar","filing":"0001551986-21-000097","document":"wf-form4_162972089443344.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198621000097/wf-form4_162972089443344.xml","form_type":"4"}},{"id":2608826,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-08-10T18:24:32.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units granted to the Reporting Person on July 30, 2020 under the Issuer's 2019 Stock Option Incentive Plan."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-08-06","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001103021-21-000078","document":"wf-form4_162863425990478.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000078/wf-form4_162863425990478.xml","form_type":"4"}},{"id":2608825,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T18:24:32.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1110595,"source":{"system":"sec-edgar","filing":"0001103021-21-000078","document":"wf-form4_162863425990478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000078/wf-form4_162863425990478.xml","form_type":"4"}},{"id":2656903,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T16:15:55.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning June 22, 2021, subject to the director's continued service with the Company at each vest date."}],"balance_after":90000,"derivative":{"exercise_price":1.38,"expiration_date":"2031-06-22","underlying":"Common stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001551986-21-000078","document":"wf-form4_162447934167071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198621000078/wf-form4_162447934167071.xml","form_type":"4"}},{"id":2714861,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T17:36:40.000Z","date":"2021-05-13","kind":"purchase","acquired":true,"shares":3000,"price":3.16,"value":9480.0,"ownership":{"direct":true},"balance_after":1106595,"source":{"system":"sec-edgar","filing":"0001103021-21-000044","document":"wf-form4_162094175756625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000044/wf-form4_162094175756625.xml","form_type":"4"}},{"id":2714860,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T17:36:40.000Z","date":"2021-05-12","kind":"purchase","acquired":true,"shares":5000,"price":3.24,"value":16200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 12, 2021, the Reporting Person purchased an aggregate of 5,000 shares of the Issuer's Common Stock at a weighted average price of $3.24 per share. The highest purchase price for the Common Stock was $3.25 per share and the lowest purchase price was $3.22 per share."}],"balance_after":1103595,"source":{"system":"sec-edgar","filing":"0001103021-21-000044","document":"wf-form4_162094175756625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000044/wf-form4_162094175756625.xml","form_type":"4"}},{"id":2714859,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-13T17:36:40.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":7500,"price":3.16,"value":23700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2021, the Reporting Person purchased an aggregate of 7,500 shares of the Issuer's Common Stock at a weighted average price of $3.16 per share. The highest purchase price for the Common Stock was $3.17 per share and the lowest purchase price was $3.15 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in these footnotes."}],"balance_after":1098595,"source":{"system":"sec-edgar","filing":"0001103021-21-000044","document":"wf-form4_162094175756625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302121000044/wf-form4_162094175756625.xml","form_type":"4"}},{"id":2755503,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-04-06T16:19:08.000Z","date":"2021-04-05","kind":"purchase","acquired":true,"shares":300000,"price":1,"value":300000.0,"ownership":{"direct":true},"balance_after":1074066,"source":{"system":"sec-edgar","filing":"0001551986-21-000048","document":"wf-form4_161774029913081.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198621000048/wf-form4_161774029913081.xml","form_type":"4"}},{"id":2939648,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-12-17T16:17:23.000Z","date":"2020-12-15","kind":"purchase","acquired":true,"shares":230769,"price":0.65,"value":149999.85,"ownership":{"direct":true},"balance_after":774066,"source":{"system":"sec-edgar","filing":"0001551986-20-000330","document":"wf-form4_160823982554853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000330/wf-form4_160823982554853.xml","form_type":"4"}},{"id":2949523,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2020-12-12T00:42:37.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":145000,"derivative":{"exercise_price":6.36,"exercise_date":"2021-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001513162-20-000237","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000237/primary_doc.xml","form_type":"4"}},{"id":2994407,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-11-03T16:14:15.000Z","date":"2020-10-30","kind":"other","acquired":true,"shares":4513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock of the Issuer reported on this Form 4 were released from escrow pursuant to Section 1.12 of that certain Agreement and Plan of Merger and Reorganization dated as of October 6, 2019 (as amended by Amendment No. 1 thereto, dated as of December 17, 2019). The Reporting Person's right to receive such escrowed shares became fixed and irrevocable on October 30, 2020, the six-month anniversary of the closing date of the merger."}],"balance_after":543297,"source":{"system":"sec-edgar","filing":"0001551986-20-000293","document":"wf-form4_160443804155615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000293/wf-form4_160443804155615.xml","form_type":"4"}},{"id":3032147,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-09-14T08:06:50.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":21485,"price":0.6518,"value":14003.923,"ownership":{"direct":false,"nature":"by spouse"},"balance_after":21485,"source":{"system":"sec-edgar","filing":"0001551986-20-000267","document":"wf-form4_160008519522242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000267/wf-form4_160008519522242.xml","form_type":"4"}},{"id":3032146,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-09-14T08:06:50.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":77000,"price":0.68,"value":52360.0,"ownership":{"direct":true},"balance_after":538784,"source":{"system":"sec-edgar","filing":"0001551986-20-000267","document":"wf-form4_160008519522242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000267/wf-form4_160008519522242.xml","form_type":"4"}},{"id":3032145,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-09-14T08:06:50.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":50000,"price":0.6,"value":30000.0,"ownership":{"direct":true},"balance_after":461784,"source":{"system":"sec-edgar","filing":"0001551986-20-000267","document":"wf-form4_160008519522242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000267/wf-form4_160008519522242.xml","form_type":"4"}},{"id":3053708,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-08-18T17:19:17.000Z","date":"2020-08-17","kind":"purchase","acquired":true,"shares":100000,"price":0.56,"value":56000.0,"ownership":{"direct":true},"balance_after":411784,"source":{"system":"sec-edgar","filing":"0001551986-20-000253","document":"wf-form4_159778554220112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000253/wf-form4_159778554220112.xml","form_type":"4"}},{"id":3056207,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-17T18:58:28.000Z","date":"2020-08-14","kind":"sale","acquired":false,"shares":115000,"price":4.9,"value":563500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On August 14, 2020, the Reporting Person sold an aggregate of 115,000 shares of the Issuer's Common Stock at a weighted average price of $4.90 per share. The highest sale price for the Common Stock was $5.07 per share and the lowest sale price was $4.60 per share."}],"balance_after":1091095,"source":{"system":"sec-edgar","filing":"0001103021-20-000136","document":"wf-form4_159770509490186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000136/wf-form4_159770509490186.xml","form_type":"4"}},{"id":3056206,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-17T18:58:28.000Z","date":"2020-08-13","kind":"sale","acquired":false,"shares":85000,"price":4.53,"value":385050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 13, 2020, the Reporting Person sold an aggregate of 85,000 shares of the Issuer's Common Stock at a weighted average price of $4.53 per share. The highest sale price for the Common Stock was $4.59 per share and the lowest sale price was $4.51 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1206095,"source":{"system":"sec-edgar","filing":"0001103021-20-000136","document":"wf-form4_159770509490186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000136/wf-form4_159770509490186.xml","form_type":"4"}},{"id":3062264,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-08-11T16:55:54.000Z","date":"2020-08-07","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on July 30, 2020, as compensation for service on the Issuer's board of directors. The remaining RSUs will vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":4000,"derivative":{"exercise_price":0,"expiration_date":"2021-08-06","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001103021-20-000129","document":"wf-form4_159717934071488.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000129/wf-form4_159717934071488.xml","form_type":"4"}},{"id":3062263,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T16:55:54.000Z","date":"2020-08-07","kind":"exercise","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on July 30, 2020, as compensation for service on the Issuer's board of directors. The remaining RSUs will vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":1291095,"source":{"system":"sec-edgar","filing":"0001103021-20-000129","document":"wf-form4_159717934071488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000129/wf-form4_159717934071488.xml","form_type":"4"}},{"id":3071561,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-08-03T17:50:10.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on July 30, 2020, pursuant to a grant under the Company's 2019 Stock Option Incentive Plan. The awards are subject to time-based vesting and will vest as follows: (i) 4,000 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and (ii) 4,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":8000,"derivative":{"exercise_price":0,"expiration_date":"2021-08-06","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001103021-20-000111","document":"wf-form4_159649139008187.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000111/wf-form4_159649139008187.xml","form_type":"4"}},{"id":3071560,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2020-08-03T17:50:10.000Z","date":"2020-07-30","kind":"grant","acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options (\"options\") were issued to the Reporting Person on July 30, 2020, pursuant to a grant under the Company's 2019 Stock Option Incentive Plan.  The awards are subject to time-based vesting and will vest as follows: (i) 24,000 options vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and (ii) 24,000 options vest in the first open window following the Company's 2021 Annual Meeting of Stockholders."}],"balance_after":48000,"derivative":{"exercise_price":4.36,"expiration_date":"2030-07-29","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001103021-20-000111","document":"wf-form4_159649139008187.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000111/wf-form4_159649139008187.xml","form_type":"4"}},{"id":3086250,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-08T16:30:42.000Z","date":"2020-07-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning July 6, 2020."}],"balance_after":100000,"derivative":{"exercise_price":0.6216,"expiration_date":"2030-07-06","underlying":"Common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001551986-20-000225","document":"wf-form4_159424022821031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000225/wf-form4_159424022821031.xml","form_type":"4"}},{"id":3091131,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-02T16:23:29.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":2544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-04","underlying":"Common stock","underlying_shares":254400},"source":{"system":"sec-edgar","filing":"0001551986-20-000204","document":"wf-form4_159372139303329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000204/wf-form4_159372139303329.xml","form_type":"4"}},{"id":3091130,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-07-02T16:23:29.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":254400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":311784,"source":{"system":"sec-edgar","filing":"0001551986-20-000204","document":"wf-form4_159372139303329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000204/wf-form4_159372139303329.xml","form_type":"4"}},{"id":3108621,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-06-16T16:05:30.000Z","date":"2020-06-15","kind":"purchase","acquired":true,"shares":17943,"price":0.5975,"value":10720.9425,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions ranging from $0.5925 and $0.60, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4."}],"balance_after":57384,"source":{"system":"sec-edgar","filing":"0001551986-20-000174","document":"wf-form4_159233791299921.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000174/wf-form4_159233791299921.xml","form_type":"4"}},{"id":3153062,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-12T18:48:32.000Z","date":"2020-05-11","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-05-11","expiration_date":"2020-05-11","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001103021-20-000081","document":"wf-form4_158932369364623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000081/wf-form4_158932369364623.xml","form_type":"4"}},{"id":3153061,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T18:48:32.000Z","date":"2020-05-11","kind":"exercise","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended."}],"balance_after":1287095,"source":{"system":"sec-edgar","filing":"0001103021-20-000081","document":"wf-form4_158932369364623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000081/wf-form4_158932369364623.xml","form_type":"4"}},{"id":3153060,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T18:48:32.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":100000,"price":5.07,"value":507000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 8, 2020, the Reporting Person sold an aggregate of 100,000 shares of the Issuer's Common Stock at a weighted average price of $5.07 per share. The highest sale price for the Common Stock was $5.29 per share and the lowest sale price was $5.00 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1264595,"source":{"system":"sec-edgar","filing":"0001103021-20-000081","document":"wf-form4_158932369364623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000081/wf-form4_158932369364623.xml","form_type":"4"}},{"id":3163426,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Warrant","published_at":"2020-05-04T19:19:43.000Z","date":"2020-05-04","kind":"purchase","acquired":true,"shares":2544,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The purchase price of the warrant was included with the purchase price of the Series A Convertible Preferred Stock. The Series A Preferred Warrant is convertible into Series A Preferred Stock on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of the warrant was included with the purchase price of the Series A Convertible Preferred Stock. The Series A Preferred Warrant is convertible into Series A Preferred Stock on a 1-for-1 basis."}],"balance_after":254400,"derivative":{"exercise_date":"2020-05-04","expiration_date":"2025-05-04","underlying":"Common stock","underlying_shares":254400},"source":{"system":"sec-edgar","filing":"0001551986-20-000126","document":"wf-form4_158863436611737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000126/wf-form4_158863436611737.xml","form_type":"4"}},{"id":3163425,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-05-04T19:19:43.000Z","date":"2020-05-04","kind":"purchase","acquired":true,"shares":2544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The purchase price of the Series A Convertible Preferred Stock was $58.94 per share. The Series A Preferred Stock is convertible into Common Stock upon stockholder approval on a 1-for-100 basis, with no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The purchase price of the Series A Convertible Preferred Stock was $58.94 per share. The Series A Preferred Stock is convertible into Common Stock upon stockholder approval on a 1-for-100 basis, with no expiration date."}],"balance_after":254400,"derivative":{"exercise_date":"2020-05-04","underlying":"Common stock","underlying_shares":254400},"source":{"system":"sec-edgar","filing":"0001551986-20-000126","document":"wf-form4_158863436611737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000126/wf-form4_158863436611737.xml","form_type":"4"}},{"id":3163424,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-04T19:18:45.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning April 30, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.7,"expiration_date":"2030-04-30","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001551986-20-000125","document":"wf-form4_158863430740168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301715/000155198620000125/wf-form4_158863430740168.xml","form_type":"4"}},{"id":3167587,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T16:10:48.000Z","date":"2020-04-27","kind":"sale","acquired":false,"shares":100000,"price":4.58,"value":458000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 27, 2020, the Reporting Person sold an aggregate of 100,000 shares of the Issuer's Common Stock at a weighted average price of $4.58 per share. The highest sale price for the Common Stock was $4.63 per share and the lowest sale price was $4.50 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1364595,"source":{"system":"sec-edgar","filing":"0001103021-20-000060","document":"wf-form4_158819102893177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000060/wf-form4_158819102893177.xml","form_type":"4"}},{"id":3172824,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:57:21.000Z","date":"2020-04-21","kind":"sale","acquired":false,"shares":5000,"price":8.1063,"value":40531.5,"ownership":{"direct":true},"balance_after":8700,"source":{"system":"sec-edgar","filing":"0001513162-20-000089","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000089/primary_doc.xml","form_type":"4"}},{"id":3172823,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:57:21.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":2454,"price":8.077,"value":19820.958,"ownership":{"direct":true},"balance_after":13700,"source":{"system":"sec-edgar","filing":"0001513162-20-000089","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000089/primary_doc.xml","form_type":"4"}},{"id":3172822,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:57:21.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":1302,"price":8.07,"value":10507.14,"ownership":{"direct":true},"balance_after":16154,"source":{"system":"sec-edgar","filing":"0001513162-20-000089","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000089/primary_doc.xml","form_type":"4"}},{"id":3172821,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:57:21.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":1076,"price":8.05,"value":8661.8,"ownership":{"direct":true},"balance_after":17456,"source":{"system":"sec-edgar","filing":"0001513162-20-000089","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000089/primary_doc.xml","form_type":"4"}},{"id":3172820,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:57:21.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":100,"price":8.06,"value":806.0,"ownership":{"direct":true},"balance_after":18532,"source":{"system":"sec-edgar","filing":"0001513162-20-000089","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000089/primary_doc.xml","form_type":"4"}},{"id":3172819,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-21T20:57:21.000Z","date":"2020-04-17","kind":"sale","acquired":false,"shares":68,"price":8.09,"value":550.12,"ownership":{"direct":true},"balance_after":18632,"source":{"system":"sec-edgar","filing":"0001513162-20-000089","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000089/primary_doc.xml","form_type":"4"}},{"id":3174365,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-17T16:05:10.000Z","date":"2020-04-15","kind":"sale","acquired":false,"shares":50000,"price":4.13,"value":206500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On April 15, 2020, the Reporting Person sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $4.13 per share. The highest sale price for the Common Stock was $4.22 per share and the lowest sale price was $4.03 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1464595,"source":{"system":"sec-edgar","filing":"0001103021-20-000056","document":"wf-form4_158715389257065.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000056/wf-form4_158715389257065.xml","form_type":"4"}},{"id":3203029,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-18T16:17:36.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":36471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of 36,471 Restricted Stock Units (RSUs) granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."}],"balance_after":1514595,"source":{"system":"sec-edgar","filing":"0001103021-20-000051","document":"wf-form4_158456263865709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000051/wf-form4_158456263865709.xml","form_type":"4"}},{"id":3314658,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-09T16:03:30.000Z","date":"2020-01-07","kind":"sale","acquired":false,"shares":13353,"price":5.65,"value":75444.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 7, 2020, the Reporting Person sold an aggregate of 13,353 shares of the Issuer's Common Stock at a weighted average price of $5.65 per share. The highest sale price for the Common Stock was $5.80 per share and the lowest sale price was $5.56 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1478124,"source":{"system":"sec-edgar","filing":"0001103021-20-000006","document":"wf-form4_157860379285944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000006/wf-form4_157860379285944.xml","form_type":"4"}},{"id":3319106,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T20:48:44.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":18600,"price":5.84,"value":108624.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On January 6, 2020 the Reporting Person sold an aggregate of 18,600 shares of the Issuer's Common Stock at a weighted average price of $5.84 per share. The highest sale price for the Common Stock was $5.92 per share and the lowest sale price was $5.75 per share."}],"balance_after":1491477,"source":{"system":"sec-edgar","filing":"0001103021-20-000004","document":"wf-form4_157836170766366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000004/wf-form4_157836170766366.xml","form_type":"4"}},{"id":3319105,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T20:48:44.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":13857,"price":6,"value":83142.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 3, 2020, the Reporting Person sold an aggregate of 13,857 shares of the Issuer's Common Stock at a weighted average price of $6.00 per share. The highest sale price for the Common Stock was $6.13 per share and the lowest sale price was $5.88 per share."}],"balance_after":1510077,"source":{"system":"sec-edgar","filing":"0001103021-20-000004","document":"wf-form4_157836170766366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000004/wf-form4_157836170766366.xml","form_type":"4"}},{"id":3319104,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T20:48:44.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":54190,"price":6.09,"value":330017.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 2, 2020, the Reporting Person sold an aggregate of 54,190 shares of the Issuer's Common Stock at a weighted average price of $6.09 per share. The highest sale price for the Common Stock was $6.36 per share and the lowest sale price was $5.86 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1523934,"source":{"system":"sec-edgar","filing":"0001103021-20-000004","document":"wf-form4_157836170766366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302120000004/wf-form4_157836170766366.xml","form_type":"4"}},{"id":3333320,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2019-12-23T21:55:04.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"N/A"}],"balance_after":125000,"derivative":{"exercise_price":2.81,"exercise_date":"2020-12-20","expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001513162-19-000260","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316219000260/primary_doc.xml","form_type":"4"}},{"id":3389839,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-22T16:36:18.000Z","date":"2019-10-18","kind":"sale","acquired":false,"shares":84228,"price":5.15,"value":433774.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 18, 2019, the Reporting Person sold an aggregate of 84,228 shares of the Issuer's Common Stock at a weighted average price of $5.15 per share. The highest sale price for the Common Stock was $5.16 per share and the lowest sale price was $5.15 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."}],"balance_after":1578124,"source":{"system":"sec-edgar","filing":"0001103021-19-000023","document":"wf-form4_157177654771191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000023/wf-form4_157177654771191.xml","form_type":"4"}},{"id":3392246,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T17:32:59.000Z","date":"2019-10-17","kind":"sale","acquired":false,"shares":31860,"price":5.15,"value":164079.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On October 17, 2019, the Reporting Person sold an aggregate of 31,860 shares of the Issuer's Common Stock at a weighted average price of $5.15 per share. The highest sale price for the Common Stock was $5.17 per share and the lowest sale price was $5.15 per share."}],"balance_after":1662352,"source":{"system":"sec-edgar","filing":"0001103021-19-000021","document":"wf-form4_157134795109990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000021/wf-form4_157134795109990.xml","form_type":"4"}},{"id":3392245,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T17:32:59.000Z","date":"2019-10-16","kind":"sale","acquired":false,"shares":8912,"price":5.15,"value":45896.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 16, 2019, the Reporting Person sold an aggregate of 8,912 shares of the Issuer's Common Stock at a weighted average price of $5.15 per share. The highest sale price for the Common Stock was $5.16 per share and the lowest sale price was $5.15 per share."}],"balance_after":1694212,"source":{"system":"sec-edgar","filing":"0001103021-19-000021","document":"wf-form4_157134795109990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000021/wf-form4_157134795109990.xml","form_type":"4"}},{"id":3392244,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T17:32:59.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":103321,"price":4.98,"value":514538.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On October 15, 2019, the Reporting Person sold an aggregate of 103,321 shares of the Issuer's Common Stock at a weighted average price of $4.98 per share. The highest sale price for the Common Stock was $5.06 per share and the lowest sale price was $4.95 per share."}],"balance_after":1703124,"source":{"system":"sec-edgar","filing":"0001103021-19-000021","document":"wf-form4_157134795109990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000021/wf-form4_157134795109990.xml","form_type":"4"}},{"id":3409995,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T17:02:11.000Z","date":"2019-09-19","kind":"sale","acquired":false,"shares":24506,"price":4.79,"value":117383.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On September 19, 2019, the Reporting Person sold an aggregate of 24,506 shares of the Issuer's Common Stock at a weighted average price of $4.79 per share. The highest sale price for the Common Stock was $4.86 per share and the lowest sale price was $4.69 per share."}],"balance_after":1806445,"source":{"system":"sec-edgar","filing":"0001103021-19-000015","document":"wf-form4_156892691588929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000015/wf-form4_156892691588929.xml","form_type":"4"}},{"id":3409994,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T17:02:11.000Z","date":"2019-09-18","kind":"sale","acquired":false,"shares":43686,"price":4.77,"value":208382.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 18, 2019, the Reporting Person sold an aggregate of 43,686 shares of the Issuer's Common Stock at a weighted average price of $4.77 per share. The highest sale price for the Common Stock was $4.81 per share and the lowest sale price was $4.73 per share."}],"balance_after":1830951,"source":{"system":"sec-edgar","filing":"0001103021-19-000015","document":"wf-form4_156892691588929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000015/wf-form4_156892691588929.xml","form_type":"4"}},{"id":3409993,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T17:02:11.000Z","date":"2019-09-17","kind":"sale","acquired":false,"shares":157177,"price":4.79,"value":752877.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 17, 2019, the Reporting Person sold an aggregate of 157,177 shares of the Issuer's Common Stock at a weighted average price of $4.79 per share. The highest sale price for the Common Stock was $4.90 per share and the lowest sale price was $4.72 per share."}],"balance_after":1874637,"source":{"system":"sec-edgar","filing":"0001103021-19-000015","document":"wf-form4_156892691588929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000110302119000015/wf-form4_156892691588929.xml","form_type":"4"}},{"id":3477344,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-27T18:00:49.000Z","date":"2019-06-25","kind":"sale","acquired":false,"shares":90706,"price":4.39,"value":398199.34,"ownership":{"direct":true},"balance_after":2031714,"source":{"system":"sec-edgar","filing":"0000899243-19-018444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319018444/doc4.xml","form_type":"4"}},{"id":3491657,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":3.47,"exercise_date":"2012-07-20","expiration_date":"2021-07-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491656,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"exercise","acquired":false,"shares":22369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":3.55,"exercise_date":"2012-02-25","expiration_date":"2021-02-25","underlying":"Common Stock","underlying_shares":22369},"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491655,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"exercise","acquired":false,"shares":37348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":3.9,"exercise_date":"2011-01-21","expiration_date":"2020-01-21","underlying":"Common Stock","underlying_shares":37348},"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491654,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-12","kind":"sale","acquired":false,"shares":177495,"price":4.21,"value":747253.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On June 12, 2019, the Reporting Person sold an aggregate of 177,495 shares of the Issuer's Common Stock at a weighted average price of $4.21 per share. The highest sale price for the Common Stock was $4.27 per share and the lowest sale price was $4.15 per share."}],"balance_after":2122420,"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491653,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"sale","acquired":false,"shares":307257,"price":4.22,"value":1296624.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On June 11, 2019, the Reporting Person sold an aggregate of 307,257 shares of the Issuer's Common Stock at a weighted average price of $4.22 per share. The highest sale price for the Common Stock was $4.42 per share and the lowest sale price was $4.15 per share."}],"balance_after":2299915,"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491652,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"exercise","acquired":true,"shares":25000,"price":3.47,"value":86750.0,"ownership":{"direct":true},"balance_after":2607172,"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491651,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"exercise","acquired":true,"shares":22369,"price":3.55,"value":79409.95,"ownership":{"direct":true},"balance_after":2582172,"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3491650,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T18:00:33.000Z","date":"2019-06-11","kind":"exercise","acquired":true,"shares":37348,"price":3.9,"value":145657.2,"ownership":{"direct":true},"balance_after":2559803,"source":{"system":"sec-edgar","filing":"0000899243-19-016870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319016870/doc4.xml","form_type":"4"}},{"id":3531864,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-10T18:03:11.000Z","date":"2019-05-09","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."}],"balance_after":22500,"derivative":{"expiration_date":"2020-05-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-19-013106","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319013106/doc4.xml","form_type":"4"}},{"id":3531863,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T18:03:11.000Z","date":"2019-05-09","kind":"exercise","acquired":true,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were acquired by the Reporting Person as a result of the vesting of 22,500 of Restricted Stock Units (\"RSUs\") granted to the Reporting Person on April 17, 2019 under the Issuer's 2011 Equity Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in the first open window upon the filing of the Company's Quarterly Report for March 31, 2020."}],"balance_after":2522455,"source":{"system":"sec-edgar","filing":"0000899243-19-013106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319013106/doc4.xml","form_type":"4"}},{"id":3552196,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-04-19T18:01:49.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options (\"options\") were issued to the Reporting Person on April 17, 2019, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 11,250 options vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for quarter ended March 31, 2019, and (ii) 11,250 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020. The exercise price of the options is the volume-weighted average price of the Issuer's Common Stock for the 30-day period ending April 16, 2019."}],"balance_after":22500,"derivative":{"exercise_price":4.96,"expiration_date":"2029-04-17","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000899243-19-010940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319010940/doc4.xml","form_type":"4"}},{"id":3552195,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-04-19T18:01:49.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (\"RSUs\") were issued to the Reporting Person on April 17, 2019, as compensation for service on the Issuer's board of directors. The RSUs vest as follows: (i) 22,500 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, and (ii) 22,500 RSUs vest in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020."}],"balance_after":45000,"derivative":{"exercise_price":0,"expiration_date":"2020-05-09","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-19-010940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319010940/doc4.xml","form_type":"4"}},{"id":3581826,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-03-22T18:00:22.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":19463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 21, 2019, the Reporting Person sold an aggregate of 9,050 shares of the Common Stock at a weighted average price of $5.20 per share. The highest sale price for the Common Stock was $5.30 per share and the lowest sale price was $5.05 per share."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2019-03-20","underlying":"Common Stock","underlying_shares":19463},"source":{"system":"sec-edgar","filing":"0000899243-19-008813","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319008813/doc4.xml","form_type":"4"}},{"id":3581825,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T18:00:22.000Z","date":"2019-03-21","kind":"sale","acquired":false,"shares":9050,"price":5.2,"value":47060.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The shares of Common Stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs."},{"field":"security","element":"securityTitle","label":"F4","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the SEC, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2019, the Reporting Person sold an aggregate of 9,050 shares of the Common Stock at a weighted average price of $5.20 per share. The highest sale price for the Common Stock was $5.30 per share and the lowest sale price was $5.05 per share."}],"balance_after":2499955,"source":{"system":"sec-edgar","filing":"0000899243-19-008813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319008813/doc4.xml","form_type":"4"}},{"id":3581824,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T18:00:22.000Z","date":"2019-03-20","kind":"grant","acquired":true,"shares":19463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Common Stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person under the Issuer's Long-Term Incentive Plan."}],"balance_after":2509005,"source":{"system":"sec-edgar","filing":"0000899243-19-008813","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319008813/doc4.xml","form_type":"4"}},{"id":3705157,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-01-04T18:02:15.000Z","date":"2019-01-02","kind":"exercise","acquired":false,"shares":9175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."}],"balance_after":0,"derivative":{"exercise_price":3.05,"exercise_date":"2010-01-22","expiration_date":"2019-01-22","underlying":"Common Stock","underlying_shares":9175},"source":{"system":"sec-edgar","filing":"0000899243-19-000560","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319000560/doc4.xml","form_type":"4"}},{"id":3705156,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T18:02:15.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":9175,"price":3.57,"value":32754.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically exercised and sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On January 2, 2019, the Reporting Person sold an aggregate of 9,175 shares of the Issuer's Common Stock at a weighted average price of $3.57 per share. The highest sale price for the Common Stock was $3.61 per share and the lowest sale price was $3.52 per share."}],"balance_after":2489542,"source":{"system":"sec-edgar","filing":"0000899243-19-000560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319000560/doc4.xml","form_type":"4"}},{"id":3705155,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T18:02:15.000Z","date":"2019-01-02","kind":"exercise","acquired":true,"shares":9175,"price":3.05,"value":27983.75,"ownership":{"direct":true},"balance_after":2498717,"source":{"system":"sec-edgar","filing":"0000899243-19-000560","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924319000560/doc4.xml","form_type":"4"}},{"id":3716965,"issuer":{"id":128876,"kind":"organization","name":"BIODELIVERY SCIENCES INTERNATIONAL INC","symbol":"BDSI"},"owners":[{"id":114901,"kind":"person","name":"Sirgo Mark A","position":1,"cik":"0001301715","reported_name":"Sirgo Mark A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-28T18:07:01.000Z","date":"2018-12-27","kind":"sale","acquired":false,"shares":10000,"price":2.91,"value":29100.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 27, 2018, the Reporting Person sold an aggregate of 10,000 shares of the Issuer's Common Stock at a weighted average price of $2.91 per share. The highest sale price for the Common Stock was $3.02 per share and the lowest sale price was $2.86 per share."}],"balance_after":2489542,"source":{"system":"sec-edgar","filing":"0000899243-18-031947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1103021/000089924318031947/doc4.xml","form_type":"4"}}],"next_cursor":"2018-12-28T18:07:01.000000Z,3716965"}